Lung function decline in children with sickle cell disease treated with hydroxyurea

Am J Hematol. 2024 Jan;99(1):E19-E21. doi: 10.1002/ajh.27134. Epub 2023 Oct 19.

Authors

Elias Seidl¹, David Wilson¹, Isaac Odame², Melanie Kirby-Allen², Hartmut Grasemann¹

Affiliations

¹ Division of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada.
² Division of Haematology/Oncology, The Hospital for Sick Children, Department of Paediatrics, Toronto, Canada.

PMID: 37859529
DOI: 10.1002/ajh.27134

No abstract available

Publication types

Letter

MeSH terms

Anemia, Sickle Cell* / complications
Anemia, Sickle Cell* / drug therapy
Antisickling Agents / therapeutic use
Child
Humans
Hydroxyurea* / therapeutic use
Lung

Substances

Hydroxyurea
Antisickling Agents